TY - JOUR
T1 - Analysis of Cytotoxicity and Immunogenic Properties of L-Asparaginase Extracted from Fungi
T2 - In Vivo Animal Model Studies
AU - Aloraini, Ghfren S.
AU - S.binshaya, Abdulkarim
AU - Alghamdi, Suad A.
AU - S.alharthi, Nahed
AU - Hjazi, Ahmed
AU - A.alqasem, Abdullah
AU - Alkahtani, Omar Saad
AU - Almasoudi, Hassan H.
AU - Aldakheel, Fahad M.
AU - Aloahd, Mustafa Sawsan
N1 - Publisher Copyright:
© 2023, Colegio de Farmaceuticos de la Provincia de Buenos Aires. All rights reserved.
PY - 2023
Y1 - 2023
N2 - This study was designed to in-vivo evaluate the enzyme’s immunogenicity and cytotoxic characteristics of the L-asparaginase from fungi with the help of molecular methods. The isolated the L-asparaginase enzyme exhibited a heavy specific activity and showed no glutaminase activity. The study evaluated the dynamic balance between the proliferation and differentiation of the cells by determining the impact of L-asparaginase on growth factors like EGF, TGF-α, bFGF and VEGF. At the time of mucosal injury, these growth factors were found to be expressed at varying rates and times. In normal cells, these factors remained the same, which in turn infers that L-asparaginase caused no injury to normal cells in the rats. The current study found that Phaseolus vulgaris (P-Asp)-isolated L-asparaginase enhances the anti-proliferative nature and the apoptotic rate of cancerous cells than the necrosis or late apoptosis of the Jurkat leukemic cell line. Further, the in vivo study results found that the mice, when treated with P-Asp, showed less distinct immune responses. This can be confirmed through the low concentrations of IgG, IgE, IgM and mMCP-1 in the serum than the rest of the treated groups. So, P-Asp is proved to be a promising candidate for the treatment of ALL.
AB - This study was designed to in-vivo evaluate the enzyme’s immunogenicity and cytotoxic characteristics of the L-asparaginase from fungi with the help of molecular methods. The isolated the L-asparaginase enzyme exhibited a heavy specific activity and showed no glutaminase activity. The study evaluated the dynamic balance between the proliferation and differentiation of the cells by determining the impact of L-asparaginase on growth factors like EGF, TGF-α, bFGF and VEGF. At the time of mucosal injury, these growth factors were found to be expressed at varying rates and times. In normal cells, these factors remained the same, which in turn infers that L-asparaginase caused no injury to normal cells in the rats. The current study found that Phaseolus vulgaris (P-Asp)-isolated L-asparaginase enhances the anti-proliferative nature and the apoptotic rate of cancerous cells than the necrosis or late apoptosis of the Jurkat leukemic cell line. Further, the in vivo study results found that the mice, when treated with P-Asp, showed less distinct immune responses. This can be confirmed through the low concentrations of IgG, IgE, IgM and mMCP-1 in the serum than the rest of the treated groups. So, P-Asp is proved to be a promising candidate for the treatment of ALL.
KW - cytotoxicity properties
KW - immunogenic
KW - L-asparaginase
UR - http://www.scopus.com/inward/record.url?scp=85176401176&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85176401176
SN - 0326-2383
VL - 42
SP - 2245
EP - 2252
JO - Latin American Journal of Pharmacy
JF - Latin American Journal of Pharmacy
IS - 11
ER -